搜索结果


   GRIN2D

靶点ID:TCMBANKGE006466


靶点别名:EB11; EIEE46; GluN2D; NMDAR2D; NR2D


靶点描述:glutamate ionotropic receptor NMDA type subunit 2D


染色体:19


染色体位置:19q13.33


靶点类型:protein-coding


HERB_ID:HBTAR001690


HGNC_Link:4588


OMIM_Link:602717


Ensembl_Link:ENSG00000105464


   靶点对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族

   靶点对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN016901 N-methyl-2-β-Hydroxypropyl piperidine C21H27NO2 CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
TCMBANKIN026559 benzenemethanol Aromatic primary alcohol; 3983-EP2298734A2; D05OIS; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 2.0-3.0 mmol loading, 1 % cross-linked; Benzyl alcohol, USP, 98.0-100.5%; NSC 406252-d5; Benzyl alcohol, Vetec(TM) reagent grade, 98%; 3983-EP2308873A1; Alcool benzilico [DCIT]; 3983-EP2311842A2; 3983-EP2292612A2; Benzyl alcohol [USAN:INN:JAN]; 3983-EP2305696A2; 3983-EP2275401A1; J-000153; WVDDGKGOMKODPV-UHFFFAOYSA-N; 3983-EP2277568A2; 3983-EP2308854A1; benzylic alcohol; TR-033774; EINECS 202-859-9; 3983-EP2272841A1; PhCH2OH; Jsp000133; Benzyl alcohol, SAJ first grade, >=98.5%; 3983-EP2298744A2; Benzyl alcohol, polymer-bound, 100-200 mesh, extent of labeling: 1.0-2.0 mmol/g loading, 1 % cross-linked with divinylbenzene; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 0.5-1.0 mmol/g loading, 1 % cross-linked with divinylbenzene; Benzoyl alcohol; CTK0H6356; 3983-EP2280010A2; 3983-EP2270011A1; Benzyl alcohol, Pharmaceutical Secondary Standard; Certified Reference Material; Benzyl alcohol, polymer-bound; NSC8044; PENTADEOTEROBENZYL ALCOHOL; Benzylalkohol; 3983-EP2292614A1; Tox21_111172; 3983-EP2308858A1; benzylalcohol; STL163453; Benzyl alcohol, puriss. p.a., ACS reagent, >=99.0% (GC); Pharmakon1600-01502555; Polystyrene cross-linked with divinylbenzene, hydroxymethylated; I01-4406; Benzyl alcohol, analytical standard; DTXSID5020152; AS04466; ZB015017; (Hydroxymethyl)benzene; Benzyl alcohol, anhydrous, 99.8%; 3983-EP2270004A1; 3983-EP2287155A1; Caswell No. 081F; 3983-EP2305808A1; Sunmorl BK 20; EC 202-859-9; Benzal alcohol; 3983-EP2275411A2; RTR-033774; benzene-methanol; 3983-EP2275102A1; 3983-EP2301931A1; 2-PHENYL-D5-ETHANOL; 3983-EP2277569A2; 3983-EP2277570A2; KB-200532; 3983-EP2308846A2; 3983-EP2316831A1; Alcool benzilico; 3983-EP2295406A1; (Hydroxymethyl)polystyrene, 200-500 mesh, extent of labeling: ~1.1 mmol/g loading; 3983-EP2305640A2; CHEMBL720; 3983-EP2308845A2; 3983-EP2280008A2; Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard; TOLUENE,ALPHA-HYDROXY; 3983-EP2295411A1; 3983-EP2292615A1; alcoholum benzylicum; BC222892; phenylmethanol; C6H5CH2OH; Phenyl-Methanol; MFCD00004599; (Hydroxymethyl)polystyrene, 200-400 mesh, extent of labeling: ~1.7 mmol/g loading; A800221; DTXSID40470349; NCGC00091865-01; InChI=1/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H; KSC176G5N; 3983-EP2280001A1; 3983-EP2287160A1; 3983-EP2289888A2; Itch-X; 3983-EP2311817A1; BENZYL ALCOHOL, U.S.P./N.F.; D00077; Benzyl alcohol, puriss., meets analytical specification of Ph.??Eur., BP, NF, 99-100.5% (GC); enzylalcohol; AKOS000119907; 2-(2,3,4,5,6-pentadeuteriophenyl)ethanol; 3983-EP2277867A2; Benzyl alcohol, >=99%, FCC, FG; Bentanol; NSC 8044; 3983-EP2380568A1; BENZYL ALCOHOL, ACS; 3983-EP2295426A1; 3983-EP2316836A1; Benzencarbinol; Phenylcarbinolum; hydroxy(phenyl)methyl; Methanol, phenyl-; Benzyl Alcohole; 3983-EP2311823A1; Benzyl alcohol (natural); Bn-OH; Benzalalcohol; Phenyl Methanol; 3983-EP2275414A1; SBB058558; 3983-EP2270505A1; C03485; 2-Phenyl-d5-ethanol, 98 atom % D, 98% (CP); a-Hydroxytoluene; 3983-EP2372017A1; EPA Pesticide Chemical Code 009502; 3983-EP2311829A1; Alcool benzylique; Benzyl alcohol, ACS reagent, >=99.0%; Alcoolbenzylique; 3983-EP2298783A1; 3983-EP2308875A1; 3983-EP2298768A1; Tox21_300044; 3983-EP2289887A2; 3983-EP2287166A2; 3983-EP2280003A2; 3983-EP2311831A1; Benzyl alcohol, LR, >=99%; 3983-EP2311806A2; I765; DSSTox_RID_75404; Benzenecarbinol; DSSTox_GSID_20152; LS41488; 3983-EP2272813A2; NCGC00254154-01; 2-[(2,3,4,5,6-(2)H?)PHENYL]ETHANOL; 3983-EP2295413A1; 3983-EP2308857A1; Phenylethyl Alcohol-d5; 3983-EP2277879A1; 3983-EP2311837A1; 3983-EP2314585A1; TB 13G; OBZ; 3983-EP2374454A1; BB_SC-7027; FT-0622812; C00556; Ulesfia; 3983-EP2305636A1; 3983-EP2305695A2; 3983-EP2277876A1; AK146334; BDBM16418; 3983-EP2314584A1; FT-0673679; CHEBI:17987; MFCD03792087; ACM35845637; Benzyl alcohol Natural; 3983-EP2305698A2; Benzyl alcohol, p.a., ACS reagent, 99.0%; Phenethyl Alcohol-d5; 3983-EP2295437A1; 3983-EP2298750A1; 4-06-00-02222 (Beilstein Handbook Reference); BIDD:ER0248; (Hydroxymethyl)polystyrene; SCHEMBL147; HMS3264B16; 3983-EP2308870A2; Polystyrene crosslinked with divinylbenzene, hydroxymethylated; AJ-24171; 3983-EP2305697A2; Nat. Benzyl Alcohol; CAS-100-51-6; 3983-EP2298755A1; 2-Phenethanol-d5; 3983-EP2270005A1; 3983-EP2374790A1; Benzyl alcohol, ReagentPlus(R), >=99%; 3983-EP2316834A1; 3983-EP2314575A1; 3983-EP2308833A2; 3983-EP2308812A2; Aromatic alcohol; 3983-EP2298743A1; 3983-EP2305651A1; Phenylmethyl alcohol; UNII-LKG8494WBH; alpha-hydroxytoluene; NCGC00259996-01; 3983-EP2295427A1; FEMA No. 2137; Benzeneethanol-d5; 3983-EP2316829A1; 3983-EP2316470A2; 3983-EP2292227A2; 100-51-6; 1336-27-2; StratoSpheres™ PL-HMS (Hydroxymethylstyrene) resin; MolPort-001-783-216; hydroxymethylbenzene; Benzylicum; 3983-EP2277565A2; NCGC00091865-02; Hydroxytoluene; a-Toluenol; 3983-EP2298775A1; Benzalcohol; Euxyl K 100; BnOH; BRN 0878307; 3983-EP2292596A2; Hydroxymethyl polystyrene; HY-B0892; Benzyl alcohol, polymer-bound, 100-200 mesh, extent of labeling: 0.5-1.0 mmol/g loading, 1 % cross-linked; CCG-213843; 3983-EP2289892A1; 3983-EP2274983A1; DSSTox_CID_152; Benzyl alcohol, natural, >=98%, FG; B2378; PINAPUR™ 9 BA-R; Benzyl alcohol, tested according to Ph.Eur.; 3983-EP2280005A1; SC-47293; 3983-EP2298731A1; benzyl alcohol; 3983-EP2272825A2; Benzyl alcohol (JP15/NF); .alpha.-Toluenol; s4600; 3983-EP2272822A1; 3983-EP2277566A2; 3983-EP2281823A2; Benzyl alcohol, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.; aplha-Hydroxytoluene; 3983-EP2279750A1; F0001-0019; 3983-EP2284160A1; Benzyl alkohol; NCGC00091865-03; Bentalol; 3983-EP2308867A2; 3983-EP2308861A1; benzenmethanol; 3983-EP2295550A2; Benzyl alcohol, AR, >=99.5%; 3983-EP2295412A1; BBL011938; HSDB 46; 3983-EP2275425A1; 3983-EP2308872A1; Alcool benzylique [INN-French]; 3983-EP2374783A1; CCRIS 2081; AI3-01680; Phenolcarbinol; 3983-EP2289884A1; Benzyl alcohol, SAJ special grade, >=99.0%; LKG8494WBH; 3983-EP2295402A2; ZINC895302; 3983-EP2298772A1; LS-307; Benzyl alcohol (JP17/NF/INN); DB06770; 3983-EP2374792A1; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 1.0-1.5 mmol/g loading, 1 % cross-linked; 3983-EP2272516A2; Alcoholum benzylicum [INN-Latin]; phenylcarbinol; 3983-EP2308844A2; phenylmethan-1-ol; 3983-EP2277848A1; Methanol benzene; 3983-EP2308877A1; Benzyl alcohol, certified reference material, TraceCERT(R); 3983-EP2289894A2; (2-Hydroxyethyl)benzene-d5; 2-Phenyl-1-ethanol-d5; SR-01000872610; Benzyl alcohol, 99% 250g; 2-Phenylethanol-d5; AC1L18SY; Benzene Carbinol; 3983-EP2287165A2; StratoSpheres(TM) PL-HMS (Hydroxymethylstyrene) resin, 50-100 mesh, extent of labeling: 2.0 mmol loading, 1 % cross-linked; 66072-40-0; 3983-EP2301936A1; Alcohol bencilico; 3983-EP2311834A1; 3983-EP2284149A1; Benzyl alcohol polymer-bound; MCULE-6011707909; NCI-C06111; Benzyl alcohol on polystyrene, 3.5 mmol/g; 35845-63-7; alpha-Toluenol; RP18893; 3983-EP2311815A1; NSC-760098; 3983-EP2292280A1; ST24048908; Alcohol bencilico [INN-Spanish]; ACMC-1BQPG; 3983-EP2301918A1; 3983-EP2311824A1; 3983-EP2269992A1; 3983-EP2277567A1; BENZYL-ALCOHOL; 3983-EP2316835A1; 3983-EP2272817A1; 3983-EP2292611A1; Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard; 3762963D-6C2A-4BFF-AD94-3180E51BCA68; ST51028320; 3983-EP2305673A1; NSC-8044; 3983-EP2292620A2; Ulesfia (TN); AC1Q7C20; NSC760098; Benzyl Alcohol Reagent ACS Grade; bmse000407; 3983-EP2308839A1; E1519; SR-01000872610-3; Benzyl alcohol [INN:JAN:NF]; NCGC00091865-04; AB01563201_01; 3983-EP2280012A2; Z955123784; 3983-EP2308828A2; 185532-71-2; .alpha.-Hydroxytoluene; WLN: Q1R; 3983-EP2305676A1; 3983-EP2311816A1; 3983-EP2305243A1; 3983-EP2298735A1; Tox21_202447 C7H8O 108.14 CO.C1=CC=CC=C1
TCMBANKIN057923 glycin Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY C2H5NO2 75.07 g/mol C(C(=O)O)N
TCMBANKIN057929 serine (s)-serine;H-Ser; Serinum [Latin]; 56-45-1; SCHEMBL1775; L-Serine, Vetec(TM) reagent grade, >=99%; bmse000867; (2S)-2-amino-3-hydroxypropanoic acid; Serine (L-Serine); EC 200-274-3; 6898-95-9; CS-W020136; L-Serine, homopolymer; CHEBI:17115; H-Ser-OH; S0035; L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture; 2-Amino-3-hydroxypropanoic acid-, (S)-; b-Hydroxy-L-alanine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-2-Amino-3-hydroxypropanoic Acid; BRN 1721404; EBD2198140; BC676679; Serinum; Serine (VAN); L-Serine;; NSC760115; (S)-(-)-Serine; AJ-24136; L-3-Hydroxy-2-aminopropionic acid; UNII-00PAR1C66F component MTCFGRXMJLQNBG-REOHCLBHSA-N; EINECS 200-274-3; TC-066532; L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%; ZINC895034; TL806218; (L)-SERINE; 61748-67-2; L-Serine, Vetec(TM), 98.5%; L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture; NCGC00015952-01; Serine (USP); beta-Hydroxyalanine; L-Serine, BioUltra, >=99.5% (NT); Racemic serine; L-Serin; (S)-beta-Amino-3-hydroxypropionate; L-(-)-Serine; NSC 118365; Pharmakon1600-01301010; BR-73019; AK-73019; AmbotzHAA1129; (-)-Serine; (S)-alpha-Amino-beta-hydroxypropionic acid; (2S)-2-amino-3-hydroxy-propanoic acid; CTK1G9788; GTPL726; 452VLY9402; DB00133; 88848-EP2289892A1; MFCD00064224; l-2-Amino-3-hydroxy-propanoic acid; (S)-(+)-2-Amino-3-hydroxypropionic acid; Tocris-0226; (2S)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL; AKOS015854115; 154605-73-9; bmse000048; alpha-Amino-beta-hydroxypropionic acid; bmse000809; MolPort-003-939-270; ser; LS-144975; 88848-EP2305825A1; (S)-a-Amino-b-hydroxypropionic acid; serine; RP09655; DB-029983; RP18847; AC1L1LHF; L-Serine (JP17); L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material; AC-1190; .beta.-Hydroxyalanine; KSC269O8R; KB-53386; BDBM50357212; RTC-066532; NCGC00024507-02; NSC-760115; Lopac-S-4250; D00016; Serina; Propanoic acid, 2-amino-3-hydroxy-, (S)-; NCGC00024507-01; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; L-Serine, United States Pharmacopeia (USP) Reference Standard; MCULE-5604658333; AM20100375; (S)-Serine; SC-09827; Tocris-0227; L-2-Amino-3-hydroxypropionic acid; bmse000885; AB1002443; UNII-452VLY9402; beta-Hydroxy-L-alanine; 064S224; Serina [Spanish]; L-Serine, Cell Culture Reagent; HSDB 680; Serine, L-; FT-0693445; Serine, European Pharmacopoeia (EP) Reference Standard; L-serine; 3h-l-serine; C00065; (S)-alpha-Amino-beta-hydroxypropionate; L-Serine, certified reference material, TraceCERT(R); Serine [USAN:INN]; 25821-52-7; .alpha.-Amino-.beta.-hydroxypropionic acid-, (S)-; 2-Amino-3-hydroxypropanoic acid, (S)-; F1905-7047; (S)-2-amino-3-hydroxy-Propanoate; (S)-beta-Amino-3-hydroxypropionic acid; L-Serine, ReagentPlus(R), >=99% (HPLC); (S)-2-Amino-3-hydroxypropionic acid; L-Serine, >=99.0% (NT); SR-01000597708; (S)-2-Amino-3-hydroxypropanoate; AN-24441; ST2408299; BP-13282; (S)-2-amino-3-hydroxy-Propanoic acid; CHEMBL11298; 3-hydroxy-L-Alanine; MTCFGRXMJLQNBG-REOHCLBHSA-N; L-Serine, tested according to Ph.Eur.; D0T6GM; PubChem10994; VC30786; Epitope ID:150900; L-3-Hydroxy-2-aminopropionate; L-3-Hydroxy-alanine; M-6047; FT-0627627; Z1270387256; SR-01000597708-1; 3AB40D3A-043A-488F-8361-D1BF309F842C; 4-04-00-03118 (Beilstein Handbook Reference); AB0008559; (S)-a-Amino-b-hydroxypropionate; SER (IUPAC abbrev); L-Alanine, 3-hydroxy-; L-ser; ACT08366; (S)-b-Amino-3-hydroxypropionate; (S)-b-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropionic acid; Poly-L-serine; ANW-32514; rac-serine;(S)-2-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropanoic acid; Serinum [Latin]; S4311_SIGMA; NCGC00024507-02; NSC 118365; Lopac-S-4250; D00016; (2S)-2-amino-3-hydroxypropanoic acid; (-)-Serine; (2S)-2-amino-3-hydroxy-propionic acid; Propanoic acid, 2-amino-3-hydroxy-, (S)-; (S)-alpha-Amino-beta-hydroxypropionic acid; 6898-95-9; (2S)-2-amino-3-hydroxy-propanoic acid; NCGC00024507-01; L-Serine, homopolymer; CHEBI:17115; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-3-Hydroxy-alanine; Tocris-0226; (S)-Serine; Tocris-0227; BRN 1721404; L-2-Amino-3-hydroxypropionic acid; beta-Hydroxy-L-alanine; Serina [Spanish]; Serine (VAN); 84959_FLUKA; alpha-Amino-beta-hydroxypropionic acid; HSDB 680; Serine, L-; C00065; 4-04-00-03118 (Beilstein Handbook Reference); L-3-Hydroxy-2-aminopropionic acid; EINECS 200-274-3; L-Serine (JAN); SER (IUPAC abbrev); Serine [USAN:INN]; 25821-52-7; 78682_FLUKA; 2-Amino-3-hydroxypropanoic acid, (S)-; L-Alanine, 3-hydroxy-; S1315_SIGMA; NCGC00015952-01; Serine (USP); Poly-L-serine; beta-Hydroxyalanine; S4500_SIGMA;L-Serin C3H7NO3 105.09 g/mol C(C(C(=O)O)N)O
TCMBANKIN057989 2-amino-4-mercaptobutanoic acid Demethylation Lindera base C4H9NO2S 135.18 C(CS)C(C(=O)O)N
TCMBANKIN058277 2-hydroxybenzoic acid O-hydroxybenzoic acid; 3- coffee acid; Thick-stemmed black base C7H6O3 or HOC6H4COOH 138.12 g/mol C1=CC=C(C(=C1)C(=O)O)O
TCMBANKIN058301 Hydroxy benzyl alcohol C7H8O2 124.14 g/mol C1=CC=C(C=C1)C(O)O
TCMBANKIN058355 Aromatic alcohol NSC 8044; Aromatic primary alcohol; HSDB 46; alpha-hydroxytoluene; benzyl alcohol; AIDS009274; AIDS-009274; CCRIS 2081; Alcohol bencilico [INN-Spanish]; (Hydroxymethyl)benzene; W213705_ALDRICH; AI3-01680; FEMA No. 2137; 4-06-00-02222 (Beilstein Handbook Reference); Hydroxytoluene; benzenemethanol; Benzyl alcohol (JP15/NF/INN); 24122_RIEDEL; 442481_SUPELCO; Phenolcarbinol; NCGC00091865-01; InChI=1/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H; Euxyl K 100; .alpha.-Toluenol; BENZYL-ALCOHOL; Caswell No. 081F; BRN 0878307; Benzoyl alcohol; C00556; Benzal alcohol; 402834_SIAL; 100-51-6; 1336-27-2; LS-307; Phenylcarbinolum; Methanol, phenyl-; 305197_ALDRICH; NSC8044; c0278; Benzyl alcohol (natural); 185532-71-2; Benzenecarbinol; hydroxymethylbenzene; C03485; Alcool benzilico [DCIT]; NCI-C06111; TOLUENE,ALPHA-HYDROXY; 108006_ALDRICH; Benzylalkohol; alpha-Toluenol; 13160_FLUKA; Benzyl alcohol [USAN:INN:JAN]; EINECS 202-859-9; CHEBI:17987; Alcoholum benzylicum [INN-Latin]; EPA Pesticide Chemical Code 009502; phenylcarbinol; 34460_RIEDEL; .alpha.-Hydroxytoluene; Benzylicum; D00077; W213713_ALDRICH; alcoholum benzylicum; benzylalcohol; phenylmethanol; Phenylmethyl alcohol; benzylic alcohol; Alcool benzylique; Alcool benzylique [INN-French];benzyl alcohol;WLN: Q1R C7H8O 108.14 g/mol C1=CC=C(C=C1)CO
TCMBANKIN058381 4-hydroxy-2-quinolinecarboxylic acid kynurenic acid; KYNA C10H7NO3 189.17 g/mol C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O
TCMBANKIN060756 isorhynchophylline C22H28N2O4 384.5 g/mol CCC1CN2CCC3(C2CC1C(=COC)C(=O)OC)C4=CC=CC=C4NC3=O
TCMBANKIN061198 1- Pentanol C5H12O 88.15 g/mol CCCCCO
TCMBANKIN061675 berberime berberine ; isoquinoline alkaloid; berberine C20H18NO4+ 336.4 g/mol COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC

   靶点对应的疾病
疾病ID 疾病名 MeSH名 HPO名 UMLS名 疾病类型
TCMBANKDI000066 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI002718 - - Finding phenotype
TCMBANKDI002881 - Abnormality of head or neck Finding phenotype
TCMBANKDI004558 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Finding phenotype
TCMBANKDI005528 Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases - Congenital Abnormality disease
TCMBANKDI007228 - - Finding phenotype
TCMBANKDI007343 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Finding phenotype
TCMBANKDI011857 Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI011883 - - Mental Process phenotype
TCMBANKDI012119 Pathological Conditions, Signs and Symptoms Abnormality of the nervous system Cell or Molecular Dysfunction phenotype
TCMBANKDI012680 - - Disease or Syndrome disease
TCMBANKDI015485 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI016612 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction phenotype
TCMBANKDI018929 Eye Diseases Abnormality of the eye Disease or Syndrome disease
TCMBANKDI019267 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Sign or Symptom phenotype
TCMBANKDI023464 Nervous System Diseases Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI024174 - Abnormality of the nervous system Finding phenotype
TCMBANKDI029658 - Abnormality of the eye Finding disease
TCMBANKDI031570 - Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI032109 Pathological Conditions, Signs and Symptoms - Disease or Syndrome disease